ImageneBio Incorporation
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol IMA:xnas
Currency USD
NASDAQ (Small cap)
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About ImageneBio Incorporation
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
Sector Healthcare
Industry Dermatology Biopharmaceuticals
Market Cap 0.100188032bn
Data Provided by 
/ 
/ Others were interested in
This information is not currently available for this instrument. Refresh the page or try again later.